Publications

Heuer R, Gaskins M, Werner RN, Nast A, Saha S. Planetary health in dermatology: towards a sustainable concept of health in clinical practice guidelines. Br J Dermatol. 2023;188(1):132-3.

Heuer R, Nast A. [Sustainable prescription and implementation practices in clinical practice guidelines]. Dermatologie (Heidelb). 2023;74(1):34-40.

Kinberger M, Werner RN, Dilling A, Blume-Peytavi U. Monomorphic vesicular exanthema in a 13-year-old boy. J Dtsch Dermatol Ges. 2023;21(5):545-7.

Nast A, Dressler C, Schuster C, Saure D, Augustin M, Reich K. Methods used for indirect comparisons of systemic treatments for psoriasis. A systematic review. Skin Health Dis. 2023;3(1):e112.

Pennitz A, Breitbart E, Clanner-Engelshofen BM, Dickel H, Eisert L, Nenoff P, et al. [Current dermatology guidelines in Germany-selected recommendations from 2021 and 2022]. Dermatologie (Heidelb). 2023;74(7):527-34.

Bauer A, Brans R, Brehler R, Büttner M, Dickel H, Elsner P, et al. S2k guideline diagnosis, prevention, and therapy of hand eczema. J Dtsch Dermatol Ges. 2023;21(9):1054-74.

Bonnekoh H, Nast A, Metz M, Dilling A. Livid papules at the distal extremities in a 14-year-old girl. J Dtsch Dermatol Ges. 2023;21(8):928-30.

Hasheminasab S, Ghoreschi FC, Meier K, Nast A, Ghoreschi K, Solimani F. Progressive enlarging yellowish indurated plaques on the neck and armpits. J Dtsch Dermatol Ges. 2023;21(10):1235-8.

Mansour Y, Bonnekoh H, Albus S, Staeck AC, Scheib C, Gräser Y, et al. Itchy nodules on the left arm after placement of a shunt. J Dtsch Dermatol Ges. 2023;21(10):1243-5.

Sbidian E, Chaimani A, Guelimi R, Garcia-Doval I, Hua C, Hughes C, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2023;7(7):Cd011535.

Solimani F, Dilling A, Ghoreschi FC, Nast A, Ghoreschi K, Meier K. Upadacitinib for treatment-resistant Lichen amyloidosis. J Eur Acad Dermatol Venereol. 2023;37(5):e633-e5.

Solimani F, Mesas-Fernández A, Bodner E, Carevic-Neri M, Hasheminasab M, Jakovljevicova T, et al. Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid. J Eur Acad Dermatol Venereol. 2023;37(6):e695-e7.

Solimani F, Mesas-Fernández A, Dilling A, Nast A, Hilke FJ, Ghoreschi FC, et al. The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus. J Eur Acad Dermatol Venereol. 2023.

Wollenberg A, Kinberger M, Arents B, Aszodi N, Barbarot S, Bieber T, et al. First update of the living European guideline (EuroGuiDerm) on atopic eczema. J Eur Acad Dermatol Venereol. 2023;37(11):e1283-e7.

Zuberbier T, Altrichter S, Bauer S, Brehler R, Brockow K, Dressler C, et al. S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria - German-language adaptation of the international S3 Guideline. J Dtsch Dermatol Ges. 2023;21(1):81-93.

Zuberbier T, Altrichter S, Bauer S, Brehler R, Brockow K, Dressler C, et al. S3 Guideline Urticaria. Part 2: Treatment of urticaria - German-language adaptation of the international S3 guideline. J Dtsch Dermatol Ges. 2023;21(2):202-15.

Kinberger M, Bonnekoh H, Dilling A, Meier K. [Granulomatous dermatoses]. Z Rheumatol. 2022;81(7):577-86.

Pennitz A, Kinberger M, Avila Valle G, Passeron T, Nast A, Werner RN. Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials. Br J Dermatol. 2022;187(3):309-17.

Scherer FD, Nast A, Gaskins M, Werner RN, Dressler C. Perioperatives Management von Antithrombotika in der Dermatochirurgie - Eine Umfrage unter Dermatologen in Deutschland. J Dtsch Dermatol Ges. 2022;20(7):941-52.

Werner RN, Dobos G, Nast A. Monkeypox: A Localized Rash Followed by General Symptoms. Deutsches Arzteblatt international. 2022;119(27-28):475.

Werner RN, Pennitz A, Eisert L, Schmidle P, Zink A, Abraham S, et al. Impact of off-label use regulations on patient care in dermatology - a prospective study of cost-coverage applications filed by tertiary dermatology clinics throughout Germany. J Eur Acad Dermatol Venereol. 2022.

Zidane M, Jungkunz HW, Kahle B, Miller A, Ochsendorf F, Sunderkötter C, et al. S1-Leitlinie: Differenzialdiagnose akuter und chronischer Rötungen der Unterschenkel. J Dtsch Dermatol Ges. 2022;20(7):1041-8.

Augustin M, Schuster C, Mert C, Nast A. The Value of Indirect Comparisons of Systemic Biologics for Psoriasis: Interpretation of Efficacy Findings. Dermatol Ther (Heidelb). 2022;12(8):1711-27.

Clanner-Engelshofen BM, Bernhard D, Dargatz S, Flaig MJ, Gieler U, Kinberger M, et al. S2k-Leitlinie: Rosazea. J Dtsch Dermatol Ges. 2022;20(8):1147-67.

Hofmann SC, Günther C, Böckle BC, Didona D, Ehrchen J, Gaskins M, et al. S2k-Leitlinie zur Diagnostik und Therapie des Schleimhautpemphigoids. J Dtsch Dermatol Ges. 2022;20(11):1530-52

Irmer ML, Nast A, Ghoreschi F, Vogt A, Ghoreschi K. Schwere bullöse Arzneimittelreaktion nach COVID-19-mRNA-Impfung. J Dtsch Dermatol Ges. 2022;20(11):1509-11.

Maurer M, Magerl M, Betschel S, Aberer W, Ansotegui IJ, Aygören-Pürsün E, et al. The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update. World Allergy Organ J. 2022;15(3):100627.

Paasch U, Zidane M, Baron JM, Bund T, Cappius HJ, Drosner M, et al. S2k-Leitlinie: Lasertherapie der Haut. J Dtsch Dermatol Ges. 2022;20(9):1248-70.

Ständer S, Zeidler C, Augustin M, Darsow U, Kremer AE, Legat FJ, et al. S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus. J Dtsch Dermatol Ges. 2022;20(10):1386-402.

Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, et al. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022.

Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, et al. European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409-31.

Xia E, Han J, Faletsky A, Baldwin H, Beleznay K, Bettoli V, et al. Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study. JAMA dermatology. 2022;158(8):942-8.

Gaskins M, Sammons MK, Kutscha F, Nast A, Werner RN. Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis-A multi-methods analysis of data from a multicentre survey. PLoS One. 2021;16(11):e0260168.

Nast A, Altenburg A, Augustin M, Boehncke WH, Härle P, Klaus J, et al. German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 2: Treatment monitoring and specific clinical or comorbid situations. J Dtsch Dermatol Ges. 2021;19(7):1092-115.

Nast A, Altenburg A, Augustin M, Boehncke WH, Härle P, Klaus J, et al. German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 1: Treatment goals and treatment recommendations. J Dtsch Dermatol Ges. 2021;19(6):934-150.

Nast A, Häfner HM, Kolk A, Koscielny J, Kunte C, Löser C, et al. S3 guideline: Management of anticoagulants and antiplatelet agents in cutaneous surgery. J Dtsch Dermatol Ges. 2021;19(10):1531-46.

Nast A, Gauglitz G, Lorenz K, Metelmann HR, Paasch U, Strnad V, et al. S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids) - Update 2020. J Dtsch Dermatol Ges. 2021;19(2):312-27.

Nast A, Smith C, Spuls PI, Avila Valle G, Bata-Csörgö Z, Boonen H, et al. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations. J Eur Acad Dermatol Venereol. 2021;35(2):281-317.

Nast A, Werner RN, Dressler C, Zidane M, Heratizadeh A, Gaskins M. [Current dermatology guidelines in Germany and Europe : A selection of clinically relevant recommendations]. Hautarzt. 2021.

Werner RN, Gaskins M, Avila Valle G, Budach V, Koswig S, Mosthaf FA, et al. State of the art treatment for stage I to III anal squamous cell carcinoma: A systematic review and meta-analysis. Radiother Oncol. 2021;157:188-96.

Werner RN, Gaskins M, Dressler C, Nast A, Schaefer C, Aigner F, et al. Measuring importance of outcomes to patients: a cross-sectional survey for the German anal cancer guideline. J Clin Epidemiol. 2021;129:40-50.

Zidane M, Eisert L, Nast A. [Vascular occlusion after filler injection with hyaluronic acid]. Hautarzt. 2021;72(4):329-31.

Aigner F, Werner RN, Koswig S, Gaskins M, Rödel C, Kahlke V, et al. [Summary and comments on the S3 guideline on anal cancer: diagnostics, treatment and aftercare of anal canal and margin cancers]. Chirurg. 2021;92(3):244-7.

Gross GE, Werner RN, Avila Valle GL, Bickel M, Brockmeyer NH, Doubek K, et al. German evidence and consensus-based (S3) guideline: Vaccination recommendations for the prevention of HPV-associated lesions. J Dtsch Dermatol Ges. 2021;19(3):479-94.

Krause T, Bonnekoh H, Dilling A, Nast A, Metz M. A distinctive bullous skin reaction associated with enfortumab vedotin-ejfv treatment for metastatic urothelial cancer: A case report. J Dtsch Dermatol Ges. 2021;19(12):1781-3.

Sammons MK, Gaskins M, Kutscha F, Nast A, Werner RN. HIV Pre-exposure Prophylaxis (PrEP): Knowledge, attitudes and counseling practices among physicians in Germany - A cross-sectional survey. PLoS One. 2021;16(4):e0250895.

Sbidian E, Chaimani A, Garcia-Doval I, Doney L, Dressler C, Hua C, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2021;4:Cd011535.

Scherer FD, Dressler C, Valles GA, Nast A. Risk of complications due to antithrombotic agents in cutaneous surgery: a systematic review and meta-analysis. J Dtsch Dermatol Ges. 2021;19(10):1421-32.

Siegel R, Werner RN, Koswig S, Gaskins M, Rödel C, Aigner F. Clinical Practice Guideline: Anal Cancer—Diagnosis, Treatment and Follow-up. Deutsches Arzteblatt international. 2021;118(Forthcoming).

Tsakok T, Rispens T, Spuls P, Nast A, Smith C, Reich K. Immunogenicity of biologic therapies in psoriasis: Myths, facts and a suggested approach. J Eur Acad Dermatol Venereol. 2021;35(2):329-37.

Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Günther C, et al. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 1: Classification, diagnosis, prevention, activity scores. J Dtsch Dermatol Ges. 2021;19(8):1236-47.

Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Günther C, et al. S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 2: Therapy, risk factors and other special topics. J Dtsch Dermatol Ges. 2021;19(9):1371-95.

Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2021.

Blume-Peytavi U, Nast A, Ghoreschi K. Wir gedenken in stiller Trauer unserem hochgeschätzten Lehrer, ehemaligen Klinikdirektor und wundervollen Menschen Prof. Dr. Wolfram Sterry. J Dtsch Dermatol Ges. 2020; 18: 1529-30.

Gilson R, Nugent D, Werner RN, et al. 2019 IUSTI-Europe guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol. 2020; 34: 1644-53.

Gross GE, Eisert L, Doerr HW, et al. S2k-Leitlinie zur Diagnostik und Therapie des Zoster und der Postzosterneuralgie. J Dtsch Dermatol Ges. 2020; 18: 55-79.

Gross GE, Eisert L, Doerr HW, et al. [S2k guideline for the diagnosis and therapy of zoster and post-zoster neuralgia]. GMS Infect Dis. 2020; 8: Doc01.

Grove GL, Banzhaf CA, Paasch U, et al. Sustained improvement of surgical scar appearance 1 year after early intervention with nonablative fractional laser treatment: a randomized controlled split-wound trial. Br J Dermatol. 2020; 183: 1138-40.

Ioannides D, Vakirlis E, Kemeny L, et al. European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol. 2020; 34: 1403-14.

Kutscha F, Gaskins M, Sammons M, et al. HIV Pre-Exposure Prophylaxis (PrEP) Counseling in Germany: Knowledge, Attitudes and Practice in Non-governmental and in Public HIV and STI Testing and Counseling Centers. Front Public Health. 2020; 8: 298.

Mayser P, Nenoff P, Reinel D, Abeck D, Brasch J, Daeschlein G, et al. S1-Leitlinie Tinea capitis. J Dtsch Dermatol Ges. 2020;18(2):161-80.

Nast A, Smith C, Spuls PI, et al. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations. J Eur Acad Dermatol Venereol. 2020; 34: 2461-98.

Sbidian E, Chaimani A, Afach S, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2020; 1: Cd011535.

Schmidt E, Sticherling M, Sárdy M, et al. S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update. J Dtsch Dermatol Ges. 2020; 18: 516-27.

Schöfer H, Enders M, Esser S, et al. [Erratum to: Diagnosis and treatment of syphilis. Update of the S2k guidelines 2020 of the German STI Society (DSTIG) in cooperation with the following specialist societies: DAIG, dagnä, DDG, DGA, DGGG, DGHM, DGI, DGN, DGPI, DGU, RKI]. Hautarzt. 2020; 71: 898.

Schöfer H, Enders M, Esser S, et al. [Diagnosis and treatment of syphilis : Update of the S2k guidelines 2020 of the German STI Society (DSTIG) in cooperation with the following specialist societies: DAIG, dagnä, DDG, DGA, DGGG, DGHM, DGI, DGN, DGPI, DGU, RKI]. Hautarzt. 2020; 71: 969-99.

Weyandt G, Breitkopf C, Werner RN, et al. S1-Leitlinie Diagnostik und Therapie des Analekzems. J Dtsch Dermatol Ges. 2020; 18: 648-57.

Wittenberg I, Mikolajczyk R, Werner RN, Wieland U, Gaskins M, Gross GE. HPV-assoziierte Neoplasien: Wie die Impfprävention gefördert werden kann. Dtsch Arztebl International. 2020;117(47):-22-.

Zidane M, Dressler C, Nast A, Egeberg A. Incidence of different cancer types in dermatomyositis, polymyositis and dermatopolymyositis: results of a registry analysis. Br J Dermatol. 2020.

Albrecht J, Barbaric J, Nast A. Rifampin alone may be enough. Is it time to abandon the classic oral clindamycin - rifampicin combination for hidradenitis suppurativa? Br J Dermatol. 2019; 180: 949-50.

Albrecht J, Barbaric J, Nast A. Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa? Reply from authors. Br J Dermatol. 2019; 180.

Bartelmann K, Gaskins M, Dressler C, Nast A. Impact of pharmaceutical industry involvement in the external review of clinical practice guidelines-A case study. J Eval Clin Pract. 2019.

Dressler C, Eisert L, Pham Thi PA, Nast A. Efficacy and safety of systemic treatments in psoriatic arthritis. A systematic review, meta-analysis and GRADE evaluation. J Eur Acad Dermatol Venereol. 2019.

Dressler C, Lambert J, Grine L, et al. Therapeutic patient education and self-management support for patients with psoriasis - a systematic review. J Dtsch Dermatol Ges. 2019.

Eisert L, Augustin M, Bach S, et al. S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 1. J Dtsch Dermatol Ges. 2019; 17: 856-70.

Eisert L, Augustin M, Bach S, et al. S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2. J Dtsch Dermatol Ges. 2019; 17: 959-74.

Eisert L, Nast A. Treatment of extensive, recalcitrant keloids using a combination of intralesional cryosurgery, triamcinolone, 5-fluorouracil and hyaluronidase. J Dtsch Dermatol Ges. 2019.

Eisert L, Zidane M, Waigandt I, et al. Granulomatous reaction following microneedling of striae distensae. J Dtsch Dermatol Ges. 2019; 17: 443-45.

Glaser DA, Hebert AA, Nast A, et al. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 Phase 3 Randomized Controlled Trials. J Am Acad Dermatol. 2019; 80: 128-38.

Glaser DA, Hebert AA, Nast A, et al. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis. American journal of clinical dermatology. 2019.

Heppt MV, Steeb T, Berking C, Nast A. Comparison of guidelines for the management of patients with high-risk and advanced cutaneous squamous cell carcinoma - a systematic review. J Eur Acad Dermatol Venereol. 2019; 33 Suppl 8: 25-32.

Loser C, Nast A, Zeymer U. [Dermatosurgery in the age of novel oral anticoagulants/direct oral anticoagulants]. Hautarzt. 2019; 70: 850-53.

Mahler V, Nast A, Bauer A, et al. S3-Leitlinie: Durchführung des Epikutantests mit Kontaktallergenen und Arzneimitteln - Kurzfassung Teil 1. J Dtsch Dermatol Ges. 2019; 17: 1075-93.

Mahler V, Nast A, Bauer A, et al. S3-Leitlinie: Durchführung des Epikutantests mit Kontaktallergenen und Arzneimitteln - Kurzfassung Teil 2. J Dtsch Dermatol Ges. 2019; 17: 1187-207.

Mahler V, Nast A, Uter W. Methodenreport der S3-Leitlinie zur „Durchführung des Epikutantests mit Kontaktallergenen und Arzneimitteln“. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2019; 17.

Mashayekhi S, Nast A, Gaskins M, et al. Hidden treasures: Exploring selective publication of trials and trial outcomes in biologic treatment for plaque psoriasis. Br J Dermatol. 2019.

Nast A, Gaskins M, Eisert L, et al. Prioritizing topics in guideline development: results of a two-phase online survey of dermatologist members of the EADV. J Eur Acad Dermatol Venereol. 2019; 33: 227-33.

Pham PA, Dressler C, Eisert L, et al. Time until onset of action when treating psoriatic arthritis: meta-analysis and novel approach of generating confidence intervals. Rheumatol Int. 2019; 39: 605-18.

Pieper D, Ober P, Dressler C, et al. [Increasing the efficiency of guideline production: a narrative review]. Z Evid Fortbild Qual Gesundhwes. 2019; 146: 1-6.

Rosumeck S, Nast A, Dressler C. Evaluation of Ivermectin vs Permethrin for Treating Scabies-Summary of a Cochrane Review. JAMA dermatology. 2019.

Smith J, Wistow G, Holder H, Gaskins M. Evaluating the design and implementation of the whole systems integrated care programme in North West London: why commissioning proved (again) to be the weakest link. BMC health services research. 2019;19(1):228.

van der Kraaij GE, Balak DMW, Busard CI, et al. Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017. Br J Dermatol. 2019; 180: 31-42.

Werner RN, Gaskins M, Nast A, Dressler C. Correction: Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection - A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis. PLoS One. 2019; 14: e0226209.

Werner RN, Nast A. 'Surprisingly little evidence' on how best to treat actinic keratosis in organ transplant recipients. Br J Dermatol. 2019; 180: 11-12.

Zidane M, Dressler C, Gaskins M, Nast A. Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis. JAMA dermatology. 2019.

Werner RN, Gaskins M, Nast A, Dressler C. Incidence of sexually transmitted infections in men who have sex with men and who are at substantial risk of HIV infection – A meta-analysis of data from trials and observational studies of HIV pre-exposure prophylaxis. PLOS ONE. 2018;13:e0208107. doi: 10.1371/journal.pone.0208107.

Albrecht J, Barbaric J, Nast A. Rifampin alone may be enough. Is it time to abandon the classic oral clindamycin - rifampicin combination for hidradenitis suppurativa? Br J Dermatol. 2018. doi: 10.1111/bjd.17422.

Werner RN, Gaskins M, Ahrens J, Jessen H, Kutscha F, Mosdzen R, et al. Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin - A multicentre, cross-sectional survey. PLoS One. 2018;13:e0204067. doi: 10.1371/journal.pone.0204067.

Karmisholt KE, Banzhaf CA, Glud M, Yeung K, Paasch U, Nast A, et al. Laser Treatments in Early Wound Healing Improve Scar Appearance: -A Randomized Split-Wound Trial with Non-ablative Fractional Laser Exposures versus Untreated Controls. Br J Dermatol. 2018. doi: 10.1111/bjd.17076.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, et al. S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 2 - Special patient populations and treatment situations. J Dtsch Dermatol Ges. 2018;16(6):806-13.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, et al. S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment. J Dtsch Dermatol Ges. 2018;16(5):645-69.

Gaskins M, Dressler C, Werner RN, Nast A. Methods Report: Update of the German S3 Guideline for the Treatment of Psoriasis vulgaris. J Dtsch Dermatol Ges. 2018;16(5).

Rosumeck S, Nast A, Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018;4:Cd012994.

Gaskins M, Dittmann M, Eisert L, Werner RN, Dressler C, Loser C, et al. Management of antithrombotic agents in dermatologic surgery before and after publication of the corresponding German evidence-based guideline. J Dtsch Dermatol Ges. 2018;16(3):297-305.

Wohlrab J, Staubach P, Augustin M, Eisert L, Hunerbein A, Nast A, et al. S2k guidelines for the use of topical preparations on the skin. J Dtsch Dermatol Ges. 2018;16(3):376-92.

Kottner J, Jacobi L, Hahnel E, Alam M, Balzer K, Beeckman D, et al. Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative. Br J Dermatol. 2018;178(4):e279-e85.

Dressler C, Werner RN, Eisert L, Zuberbier T, Nast A, Maurer M. Chronic inducible urticaria: A systematic review of treatment options. J Allergy Clin Immunol. 2018.

Gross GE, Werner RN, Becker JC, Brockmeyer NH, Esser S, Hampl M, et al. S2k guideline: HPV-associated lesions of the external genital region and the anus - anogenital warts and precancerous lesions of the vulva, the penis, and the peri- and intra-anal skin (short version). J Dtsch Dermatol Ges. 2018;16(2):242-55.

Dressler C, Rosumeck S, Werner RN, Magerl M, Metz M, Maurer M, et al. Executive summary of the methods report for 'The EAACI/GA(2) LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update'. Allergy. 2018.

Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA(2)LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update. Allergy. 2018.

Maurer M, Magerl M, Ansotegui I, Aygoren-Pursun E, Betschel S, Bork K, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. Allergy. 2018.

Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2018;32(1):11-22.

Egeberg A, Nast A. The value and pitfalls of biologics registries for psoriasis. Br J Dermatol. 2018;178(1):301-2.

Westfechtel L, Werner RN, Dressler C, Gaskins M, Nast A. Adjuvant treatment of anogenital warts with systemic interferon: a systematic review and meta-analysis. Sex Transm Infect. 2018;94(1):21-9.

Nast A, Dilleen M, Liyanage W, Aikman L, Szczypa P, Dressler C. Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials. Br J Dermatol. 2018;178(2):400-5.

Werner RN, Steinhorst NI, Nast A, Pleyer U. [Diagnostics and management of herpes zoster ophthalmicus]. Ophthalmologe. 2017;114(10):959-72.

Werner RN, Eisert L, Nast A. Herpes Zoster – Empfehlungen der konsensbasierten Europäischen Leitlinie. Dtsch Med Wochenschr. 2017;142(20):1508-13.

Seidenschnur KEK, Dressler C, Weller K, Nast A, Werner RN. Off-label prescriptions and decisions on reimbursement requests in Germany - a retrospective analysis. J Dtsch Dermatol Ges. 2017;15(11):1103-9.

Flohr C, Abuabara K, Bath-Hextall F, Nast A, van Zuuren E. Introducing the new Evidence-Based Dermatology section. Br J Dermatol. 2017;177(4):885-7.

Dressler C, Rosumeck S, Werner RN, van der Kraaij G, van Lumig P, Wakkee M, Spuls P, Nast A. Methods report: European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2017;31(12):1964-1977.

Nast A, Spuls PI, van der Kraaij G, Gisondi P, Paul C, Ormerod AD, Saiag P, Smith CH, Dauden E, de Jong EM, Feist E, Jobling R, Maccarone M, Mrowietz U, Papp KA, Reich K, Rosumeck S, Talme T, Thio HB, van de Kerkhof P, Werner RN, Dressler C. European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2017;31(12):1951-1963.

Akl EA, Meerpohl JJ, Elliott J, Kahale LA, Schunemann HJ. Living systematic reviews: 4. Living guideline recommendations. J Clin Epidemiol. 2017;91:47-53. (Dressler C collaborating author as part of the Living Systematic Review Network)

Simmonds M, Salanti G, McKenzie J, Elliott J; Living Systematic Review Network. Living systematic reviews: 3. Statistical methods for updating meta-analyses. J Clin Epidemiol. 2017;91:38-46. (Dressler C collaborating author as part of the Living Systematic Review Network)

Thomas J, Noel-Storr A, Marshall I, Wallace B, McDonald S, Mavergames C, et al. Living systematic reviews: 2. Combining human and machine effort. J Clin Epidemiol. 2017;91:31-7. (Dressler C collaborating author as part of the Living Systematic Review Network)

Elliott JH, Synnot A, Turner T, Simmonds M, Akl EA, McDonald S, Salanti G, Meerpohl J, MacLehose H, Hilton J, Tovey D, Shemilt I, Thomas J; Living Systematic Review Network. Living systematic review: 1. Introduction-the why, what, when, and how. J Clin Epidemiol. 2017;91:23-30 . (Dressler C collaborating author as part of the Living Systematic Review Network)

Heppt MV, Steeb T, Schlager JG, Rosumeck S, Dressler C, Ruzicka T, Nast A, Berking C. Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review. Cancer Treatment Reviews. 2017;60:44-52.

Ständer S, Zeidler C, Augustin M, Bayer G, Kremer AE, Legat FJ, Maisel P, Mettang T, Metz M, Nast A, Niemeier V, Raap U, Schneider G, Ständer HF, Staubach P, Streit M, Weisshaar E. S2k-Leitlinie zur Diagnostik und Therapie des chronischen Pruritus - Update - Kurzversion. J Dtsch Dermatol Ges. 2017 Aug;15(8):860-873.

Nast A, Siegel D, Bath-Hextall F, Bray N, Abuabara K. News and Notices. Br J Dermatol. 2017 Jul;177(1):326-327.

Egeberg A, Nast A. A critical eye on registry data in psoriasis. Br J Dermatol. 2017 Jul;177(1):245-246.

Dressler C, Blumeyer A, Rosumeck S, Arayesh A, Nast A. Wirksamkeit von topischem Koffein bei androgenetischer Alopezie des Mannes. J Dtsch Dermatol Ges. 2017 Jul;15(7):734-741.

Werner RN, Westfechtel L, Dressler C, Nast A. Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials. Sex Transm Infect. 2017;93(8):543-550.

Egeberg A, Gislason GH, Nast A. Birth Outcomes in Children Fathered by Men Treated with Immunosuppressant Drugs before Conception-A Danish Population-Based Cohort Study. J Invest Dermatol. 2017 Aug;137(8):1790-1792.

Albrecht J, Nast A. Paternal drug exposure: plenty of confounders, few conclusions. Br J Dermatol. 2017 Apr;176(4):847-848.

Dressler C, Rosumeck S, Nast A. Welche Behandlungsmöglichkeiten bevorzugen Akne-Patienten? J Dtsch Dermatol Ges. 2017 Jan;15(1):77-81.

Werner RN, Westfechtel L, Dressler C, Nast A. Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis. Sex Transm Infect. 2017 May;93(3):155-161.

Werner RN, Nikkels AF, Marinovic B, Schafer M, Czarnecka-Operacz M, Agius AM, Bata-Csorgo Z, Breuer J, Girolomoni G, Gross GE, Langan S, Lapid-Gortzak R, Lesser TH, Pleyer U, Sellner J, Verjans GM, Wutzler P, Dressler C, Erdmann R, Rosumeck S, Nast A. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017;31(1):9-19.

Werner RN, Nikkels AF, Marinovic B, Schafer M, Czarnecka-Operacz M, Agius AM, Bata-Csorgo Z, Breuer J, Girolomoni G, Gross GE, Langan S, Lapid-Gortzak R, Lesser TH, Pleyer U, Sellner J, Verjans GM, Wutzler P, Dressler C, Erdmann R, Rosumeck S, Nast A. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017;31(1):20-9.

Dressler C, Rosumeck S, Nast A. How Much Do We Know about Maintaining Treatment Response after Successful Acne Therapy? Systematic Review on the Efficacy and Safety of Acne Maintenance Therapy. Dermatology. 2016; 232(3): 371-80. DOI: 10.1159/000446069

Dressler C, Rosumeck S, Nast A. Reporting in the clinical trials evaluating scabies treatments. Annals of Parasitology. 2016; 62(2): 153-5. DOI: 10.17420/ap6202.48

Nast A, Rosumeck S, Dressler C, Werner RN, Ochsendorf F. Antibiotic resistance in acne. The Lancet Infectious diseases. 2016; 16(7): 775-6. DOI: 10.1016/S1473-3099(16)30076-7

Nast A, Rosumeck S, Erdmann R, Dressler C, Werner RN. [Current guidelines in dermatology : A selection of clinically relevant recommendations]. Hautarzt. 2016 Apr 6.

Sunderkötter C, Nast A, Worm M, Dengler R, Dörner T, Ganter H, Hohlfeld R, Melms A, Melzer N, Rösler K, Schmidt J, Sinnreich M, Walter MC, Wanschitz J, Wiendl H. Leitlinie Dermatomyositis - Auszug aus der interdisziplinären S2k-Leitlinie zu Myositissyndromen der deutschen Gesellschaft für Neurologie. J Dtsch Dermatol Ges. 2016 Mar;14(3):e1-e20. doi: 10.1111/ddg.12909_g.

Nast A. [Overview of dermatological registries in Germany]. Hautarzt. 2016 Feb 8.

Werner RN, Nast A. Treating actinic keratosis. Br J Dermatol. 2016 Feb;174(2):260-1. doi: 10.1111/bjd.14319.

Werner R, Rosumeck S, Erdmann R, Nast A. Online-Übersicht zu dermatologischen Registern in Deutschland – ein neues Instrument zur Stärkung der Registerforschung. J Dtsch Dermatol Ges. 2016 Feb;14(2):219-21. doi: 10.1111/ddg.12926.

Schlager JG, Rosumeck S, Werner RN, Jacobs A, Schmitt J, Schlager C, Nast A. Topical treatments for scalp psoriasis. Cochrane Database Syst Rev. 2016 Feb 26;2:CD009687. doi: 10.1002/14651858.CD009687.pub2.

Düker D, Erdmann R, Hartmann V, Nast A, Rzany B, Bachmann F. The impact of adverse reactions to injectable filler substances on quality of life: results from the Berlin Injectable Filler Safety (IFS) - study. Journal of the European Academy of Dermatology and Venereology : JEADV. 2016;30(6):1013-20. Epub 2016/02/27. doi: 10.1111/jdv.13594. PubMed PMID: 26916470.

Nast A, Griffiths CE, Hay R, Sterry W, Bolognia JL. The 2016 International League of Dermatological Societies' revised glossary for the description of cutaneous lesions. The British journal of dermatology. 2016;174(6):1351-8. Epub 2016/01/24. doi: 10.1111/bjd.14419. PubMed PMID: 26801523.

Schmitt J, Deckert S, Alam M, Apfelbacher C, Barbaric J, Bauer A, Chalmers J, Chosidow O, Delamere F, Doney E, Eleftheriadou V, Grainge M, Johannsen L, Kottner J, Le Cleach L, Mayer A, Pinart M, Prescott L, Prinsen CA, Ratib S, Schlager JG, Sharma M, Thomas KS, Weberschock T, Weller K, Werner RN, Wild T, Wilkes SR, Williams HC. Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN). The British journal of dermatology. 2016;174(2):287-95. doi: 10.1111/bjd.14337. PubMed PMID: 26779929.

Werfel T, Heratizadeh A, Aberer W, Ahrens F, Augustin M, Biedermann T, Diepgen T, Fölster-Holst R, Gieler U, Kahle J, Kapp A, Nast A, Nemat K, Ott H, Przybilla B, Roecken M, Schlaeger M, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Staab D, Worm M. S2k guideline on diagnosis and treatment of atopic dermatitis - short version. J Dtsch Dermatol Ges. 2016 Jan;14(1):92-105. doi: 10.1111/ddg.12871. Epud 2015 Dec 19.

Blumeyer A, Rowert-Huber J, Nast A, Reidel U. [Progressive facial hyperpigmentation]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2016;67(11):922-4. Epub 2016/11/01. doi: 10.1007/s00105-016-3836-9. PubMed PMID: 27393085.

Dressler C, Rosumeck S, Sunderkotter C, Werner RN, Nast A. The Treatment of Scabies. Deutsches Arzteblatt international. 2016;113(45):757-62. Epub 2016/12/16. doi: 10.3238/arztebl.2016.0757. PubMed PMID: 27974144; PubMed Central PMCID: PMCPMC5165060.

Nast A, Rosumeck S, Erdmann R, Alsharif U, Dressler C, Werner RN. Methods report on the development of the European evidence-based (S3) guideline for the treatment of acne - update 2016. Journal of the European Academy of Dermatology and Venereology : JEADV. 2016;30(8):e1-e28. Epub 2016/08/16. doi: 10.1111/jdv.13783. PubMed PMID: 27514933.

Werner RN, Westfechtel L, Dressler C, Nast A. Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis. Sexually transmitted infections. 2016. Epub 2016/11/03. doi: 10.1136/sextrans-2016-052768. PubMed PMID: 27803240.

Kuster D, Nast A, Gerdes S, Weberschock T, Wozel G, Gutknecht M, Schmitt J. Cost-effectiveness of systemic treatments for moderate-to-severe psoriasis in the German health care setting. Archives of dermatological research. 2016;308(4):249-61. Epub 2016/03/11. doi: 10.1007/s00403-016-1634-y. PubMed PMID: 26961372.

Nast A, Dreno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, Finlay AY, Haedersdal M, Lambert J, Layton A, Lomholt HB, Lopez-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Simonart T, Werner RN, Gollnick H. European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version. Journal of the European Academy of Dermatology and Venereology : JEADV. 2016;30(8):1261-8. Epub 2016/08/16. doi: 10.1111/jdv.13776. PubMed PMID: 27514932.

Schlager JG, Rosumeck S, Werner RN, Jacobs A, Schmitt J, Schlager C, Nast A. Topical treatments for scalp psoriasis: summary of a Cochrane Systematic Review. The British journal of dermatology. 2016. Epub 2016/10/21. doi: 10.1111/bjd.14811. PubMed PMID: 27312814.

Sunderkotter C, Feldmeier H, Folster-Holst R, Geisel B, Klinke-Rehbein S, Nast A, Philipp S, Sachs B, Stingl J, Stoevesandt J, Hamm H. S1-Leitlinie zur Diagnostik und Therapie der Skabies - Kurzfassung. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2016;14(11):1160-71. Epub 2016/11/24. doi: 10.1111/ddg.13130_g. PubMed PMID: 27879080.

Sunderkotter C, Feldmeier H, Folster-Holst R, Geisel B, Klinke-Rehbein S, Nast A, Philipp S, Sachs B, Stingl J, Stoevesandt J, Hamm H. S1 guidelines on the diagnosis and treatment of scabies - short version. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2016;14(11):1155-67. Epub 2016/11/24. doi: 10.1111/ddg.13130. PubMed PMID: 27879074.

Weberschock T, Dreher A, Follmann M, Nothacker M, Kopp I, Rosumek S, Nast A. [Obligation of guideline recommendations: Perception survey among guideline developers]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen. 2016;113:1-8. Epub 2016/08/03. doi: 10.1016/j.zefq.2016.05.010. PubMed PMID: 27480183.

Werner RN, Marinovic B, Rosumeck S, Strohal R, Haering NS, Weberschock T, Dreher AC, Nast A. The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument. Journal of the European Academy of Dermatology and Venereology : JEADV. 2016;30(3):395-403. Epub 2015/10/16. doi: 10.1111/jdv.13358. PubMed PMID: 26466752.

Lambert J, Nast A, Nestle FO, Prinz JC. Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: What can be learnt from other diseases? J Dermatolog Treat. 2015 Dec;26(6):520-7. doi: 10.3109/09546634.2015.1034076. Epub 2015 Jun 25.

Strohal R, Prinz JC, Girolomoni G, Nast A. A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2390-8. doi: 10.1111/jdv.13248. Epub 2015 Sep 14.

Nast A, Gisondi P, Ormerod AD, Saiag P, Smith C, Spuls PI, Arenberger P, Bachelez H, Barker J, Dauden E, de Jong E, Feist E, Jacobs A, Jobling R, Kemény L, Maccarone M, Mrowietz U, Papp KA, Paul C, Reich K, Rosumeck S, Talme T, Thio HB, van de Kerkhof P, Werner RN, Yawalkar N. European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2277-94. doi: 10.1111/jdv.13354.

Nast A, Jacobs A, Rosumeck S, Werner RN. Methods Report: European S3-Guidelines on the systemic treatment of psoriasis vulgaris - update 2015 - EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):e1-e22. doi: 10.1111/jdv.13353. Epub 2015 Oct 10.

Werner RN, Stockfleth E, Connolly SM, Correia O, Erdmann R, Foley P, Gupta AK, Jacobs A, Kerl H, Lim HW, Martin G, Paquet M, Pariser DM, Rosumeck S, Röwert-Huber HJ, Sahota A, Sangueza OP, Shumack S, Sporbeck B, Swanson NA, Torezan L, Nast A. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version. J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2069-79. doi: 10.1111/jdv.13180. Epub 2015 Sep 14.

Werner RN, Jacobs A, Rosumeck S, Erdmann R, Sporbeck B, Nast A. Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum. J Eur Acad Dermatol Venereol. 2015 Nov;29(11):e1-66. doi: 10.1111/jdv.13179. Epub 2015 Sep 9.

Nast A, Jacobs A, Rosumeck S, Werner RN. Efficacy and Safety of Systemic Long-term Treatments for Moderate-to-Severe Psoriasis-A Systematic Review and Meta-Analysis. J Invest Dermatol. 2015 Nov;135(11):2641-8. doi: 10.1038/jid.2015.206. Epub 2015 Aug 13.

Werner RN, Marinović B, Rosumeck S, Strohal R, Haering NS, Weberschock T, Dreher AC, Nast A. The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument. J Eur Acad Dermatol Venereol. 2015 Oct 14. doi: 10.1111/jdv.13358. Epub 2015 Oct 14 [Epub ahead of print]

Jacobs A, Rosumeck S, Nast A. Systematic review on the maintenance of response during systemic antipsoriatic therapy. Br J Dermatol. 2015 Oct;173(4):910-21. doi: 10.1111/bjd.14077. Epub 2015 Oct 6.

Eming R, Sticherling M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Pfeiffer C, Schuster V, Zillikens D, Goebeler M, Hertl M, Nast A, Orzechowski HD, Sárdy M, Schmidt E, Sitaru C, Sporbeck B, Worm M. S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoid. J Dtsch Dermatol Ges. 2015 Aug;13(8):833-45.

Schmidt E, Goebeler M, Hertl M, Sárdy M, Sitaru C, Eming R, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Orzechowski HD, Pfeiffer C, Schuster V, Sporbeck B, Sticherling M, Worm M, Zillikens D, Nast A. S2k-Leitlinie zur Diagnostik des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids. J Dtsch Dermatol Ges. 2015 Jul;13(7):713-27.

Radtke MA, Mrowietz U, Feuerhahn J, Härter M, von Kiedrowski R, Nast A, Reich K, Strömer K, Wohlrab J, Matthias A. Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis. J Dtsch Dermatol Ges. 2015 Jul;13(7):674-89.

Schöfer H, Weberschock T, Bräuninger W, Bremer V, Dreher A, Enders M, Esser S, Hamouda O, Hagedorn HJ, Handrick W, Krause W, Mayr C, Münstermann D, Nast A, Ochsendorf F, Petry U, Potthoff A, Prange H, Rieg S, Schneede P, Sing A, Weber J, Wichelhaus TA, Brockmeyer N. S2k guideline* "Diagnosis and therapy of syphilis"-short version. J Dtsch Dermatol Ges. 2015 Mai;13(5):472-80.

Sporbeck B, Georges Bechara F, Häfner HM, Koenen W, Kolk A, Koscielny J, Meissner M, Pokrywka A, Schirmer S, Strömer K, Löser C, Nast A. S3 guidelines for the management of anticoagulation in cutaneous surgery. J Dtsch Dermatol Ges. 2015 Apr;13(4):346-56. doi: 10.1111/ddg.12576.

Nast A, Rosumeck S, Seidenschnur K. Biosimilars: a systematic review of published and ongoing clinical trials of antipsoriatics in chronic inflammatory diseases. J Dtsch Dermatol Ges. 2015 Apr; 13(4):294-300. doi: 10.1111/ddg.12621.

Dressler C, Cabieses B. Gender differences in population-based prevalences of cardiovascular and cerebrovascular diseases in Chile: are men being under-diagnosed? International Journal of Nursing 2015: 3(2)39-50.

Gross G, Becker N, Brockmeyer NH, Esser S, Freitag U, Gebhardt M, Gissmann L, Hillemanns P, Grundhewer H, Ikenberg H, Jessen H, Kaufmann A, Klug S, Klussmann JP, Nast A, Pathirana D, Petry KU, Pfister H, Rollinghof U, Schneede P, Schneider A, Selka E, Singer S, Smola S, Sporbeck B, Doeberitz MV, Wutzler P. Vaccination against HPV-Associated Neoplasias Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018. Geburtsh Frauenheilk. 2014; 74(3):233-41.

Jacobs A, Starke G, Rosumeck S, Nast A. Systematic review on the rapidity of the onset of action of topical treatments in the therapy of mild-to-moderate acne vulgaris. Br J Dermatol. 2014; 170(3):557-64.

Mrowietz U, de Jong EM, Kragballe K, Langley R, Nast A, Puig L, Reich K, Schmitt J, Warren RB. A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol. 2014; 28(4):438-53.

Nast A, Rzany B. Confirming the hypothesis at any cost? Deutsches Arzteblatt international. 2014; 111(3):35.

Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Gimenez-Arnau A, Godse K, Goncalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sanchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014: 69(7): 868-87.

Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Gimenez-Arnau A, Godse K, Goncalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sanchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M. Methods report on the development of the 2013 revision and update of the EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2014; 69(7):e1-e29.

Ahmad Al Dhafiri S, Nast A, Jaser Al Shamary M. Hypopigmented macules in a young man. J Dtsch Dermatol Ges. 2014;12(3):272-4.

Schmitt J, Rosumeck S, Thomaschewski G, Sporbeck B, Haufe E, Nast A. Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol. 2014; 170(2):274-303.

Sunderkötter C, von Stebut E, Schöfer H, Mempel M, Reinel D, Wolf G, Meyer V, Nast A, Burchard GD. S1 guideline diagnosis and therapy of cutaneous larva migrans (creeping disease). J Dtsch Dermatol Ges. 2014; 12(1):86-91.

Wehner MR, Chren MM, Nameth D, Choudhry A, Gaskins M, Nead KT, Boscardin WJ, Linos E. International prevalence of indoor tanning: a systematic review and meta-analysis. JAMA dermatology. 2014;150(4):390-400. Epub 2014/01/31. doi: 10.1001/jamadermatol.2013.6896. PubMed PMID: 24477278; PubMed Central PMCID: PMCPMC4117411.

Nast A, Sporbeck B, Jacobs A, Erdmann R, Roll S, Sauerland U, Rosumeck S. Wahrnehmung der Verbindlichkeit von Leitlinienempfehlungen - Eine Umfrage zu häufigen Formulierungen. Dtsch Arztebl 2013; 110: 663-8.

Dressler C, Lewin RJ. UK survey of patient cardiac rehabilitation attendance. British Journal of Cardiac Nursing 2013; 8(12):603-609.

Dressler C. Improving the uptake of cardiac rehabilitation in invited patients: a multi-method evaluation (Ph.D. Thesis: http://etheses.whiterose.ac.uk/4754/) 2013. University of York.

Dressler, C. Cabieses, B. Exploring Gender Differences in Population-Based Prevalences of Cardiovascular Diseases in Chile After the Health Care Reform of 2005. Value in Health 2013; 16 (7): A708.

Nast A, Mrowietz U, Kragballe K, et al. National and multinational guidelines in Europe: results from an online survey on awareness of different national and European psoriasis guidelines. Arch Dermatol Res. 2013; 305(7):637-43.

Loser C, Zeymer U, Nast A. [Platelet inhibitors and anticoagulants: managing blood thinners in dermatosurgery]. Hautarzt. 2013; 64:553-7.

Nast A, Sporbeck B, Rosumeck S, et al. Which Antipsoriatic Drug Has the Fastest Onset of Action?-Systematic Review on the Rapidity of the Onset of Action. J Invest Dermatol. 2013; 133(8):1963-70.

Rzany B, Nast A. Acne treatment in the field: how guidelines and other sources can be included in daily practice. J Eur Acad Dermatol Venereol. 2013; 27 Suppl 2:2-5.

Nast A, Grabbe S. Editorial: Update guidelines dermatologic oncology. J Dtsch Dermatol Ges. 2013; 11 Suppl 3:1.

Nast A, Schmitt J. Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis. J Am Acad Dermatol. 2013; 68(6):1040-1.

Wohlrab J, Fiedler G, Gerdes S, et al. Recommendations for detection of individual risk for comorbidities in patients with psoriasis. Arch Dermatol Res. 2013; 305(2):91-8.

Rzany B, Bachmann F, Nast A. [Adverse reaction to fillers. Diagnosis and management]. Hautarzt. 2013; 64(3):163-70.

Rzany B, Bachmann F, Nast A. [Injectable fillers: adverse reactions and their management]. Hautarzt. 2013; 64(2):117-25; quiz 126-7.

Sporbeck B, Jacobs A, Hartmann V, Nast A. Methodological standards in medical reporting. J Dtsch Dermatol Ges. 2013; 11(2):107-20.

Nast A, Ernst H, Rosumeck S, et al. Management of anticoagulation during dermatosurgical procedures in Germany - results from a cross-sectional study. J Dtsch Dermatol Ges. 2013; 11(1):52-9.

Nast A, Mrowietz U, Kragballe K, et al. Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis--a multinational cross-sectional study. Arch Dermatol Res. 2013; 305:899-907.

Nast A, Rosumeck S, Erdmann R, Werner RN. Can physician's self-estimates be used as a valid instrument to determine prescription frequencies of anti-psoriatic drugs? Comparison of the results of a cross-sectional study using self-estimates with actual prescription behavior documented in a cohort study. Pharmacoepidemiol Drug Saf. 2013; 22:1154-8.

Werner RN, Sammain A, Erdmann R, et al. The natural history of actinic keratosis: a systematic review. Br J Dermatol 2013; 169: 502-18.

Lucka TC, Pathirana D, Sammain A, Bachmann F, Rosumeck S, Erdmann R, Schmitt J, Orawa H, Rzany B, Nast A. Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment. J Eur Acad Dermatol Venereol 2012; 26: 1331-44.

Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Muller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B. S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges 2012; 10 Suppl 2: S1-95.

Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Muller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B. German S3-guidelines on the treatment of psoriasis vulgaris (short version). Arch Dermatol Res 2012; 304: 87-113.

Nast A, Dreno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, Ganceviciene R, Haedersdal M, Layton A, Lopez-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Rzany B, Sammain A, Simonart T, Veien NK, Zivkovic MV, Zouboulis CC, Gollnick H. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012; 26 Suppl 1: 1-29.

Nast A, Eming S, Fluhr J, Fritz K, Gauglitz G, Hohenleutner S, Panizzon RG, Sebastian G, Sporbeck B, Koller J. German S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids). J Dtsch Dermatol Ges 2012; 10: 747-60.

Dressler C, Pattenden J, Atkin K, Lewin RJ. Interventions to increase the uptake of cardiac rehabilitation: Systematic review. British Journal of Cardiac Nursing 2012; 7(7): 338-345.

Nast A, Kragballe, K, Reich K, Mrowietz, U. National and multinational guidelines - What do we need? Online survey on awareness of different national and European psoriasis guidelines. (Zum Poster)

Nast A, Rosumeck S, Sammain A, Sporbeck B, Rzany B. Methods report on the development of the European S3 guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012; 26 Suppl 1: e1-41.

Nast A, Rosumeck S, Sporbeck B, Rzany B. [Using new media for online consensus conferences and open external review of guidelines - results of two pilot studies]. Z Evid Fortbild Qual Gesundhwes 2012; 106: 295-301.

Sporbeck B, Rosumeck S, Pathirana D, Erdmann R, Nast A. The importance of wording in guidelines recommendation - A German evaluation - (Zum Poster)

Dressler C. Strategies Promoting the Participation In Prevention And Rehabilitation Services: An Overview Of Reviews. International Journal of Nursing 2012; 1(1):8-14.

Ascher B, Bayerl C, Brun P, Kestemont P, Rzany B, Poncet M, Guennoun M, Podda M. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines - 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Dermatol. 2011; 10: 94-8.

Bachmann F, Erdmann R, Hartmann V, Becker-Wegerich P, Wiest L, Rzany B. Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the Injectable Filler Safety study. J Eur Acad Dermatol Venereol. 2011; 25: 902-12.

Bachmann F, Erdmann R, Hartmann V, Rzany B. Consecutively injected fillers in the same region do not pose an increased risk for adverse reactions. J Eur Acad Dermatol Venereol. 2011; 25: 737-8.

Fluhr JW,  Nast A. Maintenance therapy: acne as a chronic disease. Br J Dermatol. 2011; 164: 1181-2.

Mrowietz U, Kragballe K, Nast A, Reich K. Strategies for improving the quality of care in psoriasis with the use of treatment goals--a report on an implementation meeting. J Eur Acad Dermatol Venereol. 2011; 25 Suppl 3: 1-13.

Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Daudén E, Gisondi P, Iversen L, Kemény L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011; 303: 1-10

Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Muller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B. [S3-guidelines for the treatment of psoriasis vulgaris Update 2011]. J Dtsch Dermatol Ges. 2011; 9 Suppl 2: S1-104.

Nast A, Rosumeck S, Sammain A, Erdmann R, Sporbeck B, Rzany B. [S3-guidelines for the treatment of psoriasis vulgaris--methods report]. J Dtsch Dermatol Ges. 2011; 9 Suppl 2: e64-84.

Nast A, Reytan N, Hartmann V, Pathirana D, Bachmann F, Erdmann R, Rzany B. Efficacy and durability of two hyaluronic Acid-based fillers in the correction of nasolabial folds: results of a prospective, randomized, double-blind, actively controlled clinical pilot study. Dermatol Surg. 2011; 37: 768-75.

Rosumeck S, Sporbeck B, Rzany B, Nast A. Offenlegung potenzieller Interessenkonflikte in dermatologischen Leitlinien in Deutschland - eine Analyse - Status Quo und Quo Vadis. J Dtsch Dermatol Ges. 2011;9:297-304.

Rzany B, Bayerl C, Bodokh I, Boineau D, Dirschka T, Queille-Roussel C, Sebastian M, Sommer B, Poncet M, Guennoun M, Podda M. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther. 2011; 13: 107-12.

Schofer H, Bruns R, Effendy I, Hartmann M, Jappe U, Plettenberg A, Reimann H, Seifert H, Shah P, Sunderkotter C, Weberschock T, Wichelhaus TA, Nast A. Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranes. J Dtsch Dermatol Ges. 2011; 9: 953-67

Sundmacher L, Gaskins M, Hofmann K. Spatial distribution of avoidable cancer deaths in Germany. Journal of Public Health. 2011; 20(3): 279–288.

Krezdorn N, Hartmann V, Bachmann F, Nast A, Rzany B. Ästhetische Dermatologie für Studierende: gute Akzeptanz eines neuen freiwilligen Seminars. J Dtsch Dermatol Ges. 2010;8:281-3.

Nast A, Bayerl C, Borelli C, Degitz K, Dirschka T, Erdmann R, et al. S2k-Leitlinie zur Therapie der Akne. J Dtsch Dermatol Ges. 2010;8 Suppl 2:s1-59.

Pathirana D, Nast A, Ormerod A, Reytan N, Saiag P, Smith C, Spuls P, Rzany B. On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: structure and challenges. J Eur Acad Dermatol Venereol. 2010;24:1458-67.

Rzany B, Ascher B, Monheit G. Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview. J Eur Acad Dermatol Venereol. 2010;24 Suppl 1:1-14.

Rzany B, Hilton S, Prager W, Hartmann V, Brandl G, Fischer TC et al. Expert guideline on the use of porcine collagen in aesthetic medicine. J Dtsch Dermatol Ges. 2010;8:210-7.

Sperling B, Bachmann F, Hartmann V, Erdmann R, Wiest L, Rzany B. The current state of treatment of adverse reactions to injectable fillers. Dermatol Surg. 2010;36 Suppl 3:1895-904.

Spuls PI, Nast A. Evaluation of and perspectives on guidelines: what is important? J Invest Dermatol. 2010;130:2348-9.

Henschke C, Baeumler M, Gaskins M, Busse R. Coronary stents and the uptake of new medical devices in the German system of inpatient reimbursement. Journal of interventional cardiology. 2010;23(6):546-53. Epub 2010/08/26. doi: 10.1111/j.1540-8183.2010.00592.x. PubMed PMID: 20735711.

Henscke C, Bäumler M, Weid S, Gaskins M, Busse R. Extrabudgetary (‘NUB’) payments: A gateway for introducing new medical devices into the German inpatient reimbursement system? Journal of Management and Marketing in Healthcare. 2010; 3(2): 119–133.

Ascher B, Rzany B, Grover R. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Lateral Crows Feet: Double-Blind, Placebo-Controlled, Dose-Ranging Study. Derm Surg 2009;35:1–9.

Hartmann V, Bachmann F, Plaschke M, Gottermeier T, Nast A, Rzany B. Handaugmentation mit stabilisierter Hyaluronsäure. J Dtsch Dermatol Ges. 2009;8(1):41-4.

Nast A, Spuls P, Ormerod A, Reytan N, Saiag P, Smith C, Rzany B. A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines. J Eur Acad Dermatol Venereol. 2009;23(7):782-7.

Nast A, Erdmann R, Hofelich V, Reytan N, Orawa H, Sterry W, Rzany B. Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines. Archives of Dermatological Research. 2009;301(8):553-9.

Pathirana D, Hillemanns P, Petry KU, Becker N, Brockmeyer NH, Erdmann R et al. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia. Vaccine. 2009;27(34):4551-9.

Pathirana D, Ormerod A D, Saiag P, Smith C, Spuls PI, Nast et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. Journal of the European Academy of Dermatology & Venereology. 2009;23 Suppl 2:1-70.

Roßner F, Roßner M, Hartmann V, Erdmann R, Wiest LG, Rzany B. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: eight year results from the Injectable Filler Safety-Study (IFS-Study). J Cosmet Dermatol. 2009;8(1):14-8.

Roßner M, Roßner F, Bachmann F, Wiest L, Rzany B. Increased risk of severe adverse reactions towards an injectable filler composed of a fixed combination of methacrylate particles and hyaluronic acid (Dermalive®). Derm Surgery 2009;35 Suppl 1:367-74.

Bachmann F, Rzany B. Ästhetische Medizin des Mannes: Anwendung von injizierbaren Hyalronsäurepräparaten zur Falten- und Volumenaugmentation. Kosmet Medizin 2008;29:66-74.

Hartmann V, Erdmann R, Plaschke M, Rzany B. Fortbildung Ästhetische Medizin: Hospitationskurs am anatomischen Präparat zur Augmentation des Handrückens mit injizierbaren Hyaluronsäurepräparaten. J Dtsch Dermatol Ges. 2008;6(9):751-3.

Heinz BC, Ladhoff U, Kahl Ch, Rzany B, von Mallek D. Vorkommnismeldungen zu injizierbaren Füllmaterialien. Auswertung des Medizinprodukte-Beobachtungs- und -Meldesystems in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008;51(7):787-92.

Lüdert T, Nast A, Zielke H, Sterry W, Rzany B. E-learning in the dermatological education at the Charité: evaluation of the last three years. J Dtsch Dermatol Ges. 2008;6(6):467-72.

Nast A, Rzany B. Leitlinien erstellen ist kein Nullsummenspiel. ÄP Dermatologie-Allergologie. 2008;1:28-32.

Nast A, Reytan N, Rosumeck S, Erdmann R, Rzany B. Low prescription rate for systemic treatments in the management of severe psoria sis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry. J Eur Acad Dermatol Venereol. 2008;22(11):1337-42.

Pickett A, Dodd S, Rzany B. Confusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins used in aesthetic applications. J Cosmet Laser Ther. 2008 May 23:1-3.

Reytan N, Rzany B. Porcine Filler for Facial Lipoatrophy associated with human immunodeficiency virus treatment. J Drugs Dermatol. 2008 Sept;7(9): 884-6.

Zielke H, Wölber L, Wiest L, Rzany B. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg. 2008 Mar;34(3):326-35.